{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:15:37Z","timestamp":1786119337620,"version":"build-2736575974"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>A substantial proportion of living kidney donor candidates are hypertensive or diagnosed with hypertension during the evaluation process. Furthermore, many donors develop hypertension after nephrectomy as they age, similar to nondonors. In this article, we review the data available from the general population and donor cohorts relevant to the risk of development of hypertension after donation, and the risk associated with pre-existing hypertension. Large long-term data show that treatment and control of hypertension mitigate the cardiovascular mortality risk associated with hypertension. Given the bidirectional relationship between hypertension and chronic kidney disease, whether milder forms of hypertension increase the risk of kidney disease is less clear; however, the absolute risk appears to be low. While retrospective studies provide conflicting results, several prospective studies with well-selected nondonor controls demonstrate no longitudinal differences in blood pressure. Data on donors with pre-existing hypertension, albeit limited and heterogeneous, are overall reassuring. We provide an overview of the major guidelines currently used in the evaluation of hypertensive kidney donors, and also outline our center\u2019s approach to these candidates. A major limitation of the available body of literature is the paucity of studies focusing on minority populations, including Blacks and medically complex donors with multiple additional risk factors. Ongoing investigation using updated blood pressure measurement techniques, definition, and treatment guidelines and including medically complex and minority populations are needed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/tp.0000000000005735","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T19:00:12Z","timestamp":1777316412000},"page":"e1384-e1390","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Living Kidney Donation and Hypertension"],"prefix":"10.1097","volume":"110","author":[{"given":"Neetika","family":"Garg","sequence":"first","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier A.","family":"Mandelbrot","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,4,27]]},"reference":[{"key":"R2-20260616","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1111\/ajt.15964","article-title":"The metabolic, cardiovascular and substance use evaluation of living kidney donor candidates: US practices in 2017.","volume":"12","author":"Garg","year":"2020","journal-title":"Am J Transplant"},{"key":"R3-20260616","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1111\/j.1600-6143.2007.01932.x","article-title":"The medical evaluation of living kidney donors: a survey of US transplant centers.","volume":"7","author":"Mandelbrot","year":"2007","journal-title":"Am J Transplant"},{"key":"R4-20260616","doi-asserted-by":"crossref","first-page":"14802","DOI":"10.3389\/ti.2025.14802","article-title":"Living kidney donation practices in Europe: a survey of DESCaRTES and EKITA transplantation working groups.","volume":"38","author":"van Londen","year":"2025","journal-title":"Transpl Int"},{"key":"R5-20260616","first-page":"e13","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines.","volume":"71","author":"Whelton","year":"2018","journal-title":"Hypertension"},{"key":"R7-20260616","first-page":"1","article-title":"Mortality in the United States, 2021.","volume":"456","author":"Xu","year":"2022","journal-title":"NCHS Data Brief"},{"key":"R8-20260616","doi-asserted-by":"crossref","first-page":"9418","DOI":"10.1038\/s41598-018-27377-2","article-title":"Uncontrolled hypertension increases risk of all-cause and cardiovascular disease mortality in US adults: the NHANES III linked mortality study.","volume":"8","author":"Zhou","year":"2018","journal-title":"Sci Rep"},{"key":"R9-20260616","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1056\/NEJMoa1901281","article-title":"Final report of a trial of intensive versus standard blood-pressure control.","volume":"384","author":"Group","year":"2021","journal-title":"N Engl J Med"},{"key":"R10-20260616","doi-asserted-by":"crossref","first-page":"375","DOI":"10.7326\/M16-2966","article-title":"Effects of intensive systolic blood pressure control on kidney and cardiovascular outcomes in persons without kidney disease: a secondary analysis of a randomized trial.","volume":"167","author":"Beddhu","year":"2017","journal-title":"Ann Intern Med"},{"key":"R11-20260616","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/ki.2013.460","article-title":"Long-term risks for kidney donors.","volume":"86","author":"Mjoen","year":"2014","journal-title":"Kidney Int"},{"key":"R12-20260616","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1001\/jama.2013.285141","article-title":"Risk of end-stage renal disease following live kidney donation.","volume":"311","author":"Muzaale","year":"2014","journal-title":"JAMA"},{"key":"R13-20260616","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy.","volume":"345","author":"Brenner","year":"2001","journal-title":"N Engl J Med"},{"key":"R14-20260616","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1001\/archinte.165.8.923","article-title":"Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease.","volume":"165","author":"Hsu","year":"2005","journal-title":"Arch Intern Med"},{"key":"R15-20260616","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1510491","article-title":"Kidney-failure risk projection for the living kidney-donor candidate.","volume":"374","author":"Grams","year":"2016","journal-title":"N Engl J Med"},{"key":"R16-20260616","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/0140-6736(92)92683-7","article-title":"20 years or more of follow-up of living kidney donors.","volume":"340","author":"Najarian","year":"1992","journal-title":"Lancet"},{"key":"R17-20260616","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/TP.0b013e31817ba9e3","article-title":"Cardiovascular disease and hypertension risk in living kidney donors: an analysis of health administrative data in Ontario, Canada.","volume":"86","author":"Garg","year":"2008","journal-title":"Transplantation"},{"key":"R18-20260616","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.2215\/CJN.04020419","article-title":"Self-reported incident hypertension and long-term kidney function in living kidney donors compared with healthy nondonors.","volume":"14","author":"Holscher","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"key":"R19-20260616","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/tri.13576","article-title":"Increased long-term risk for hypertension in kidney donors\u2014a retrospective cohort study.","volume":"33","author":"Haugen","year":"2020","journal-title":"Transpl Int"},{"key":"R20-20260616","doi-asserted-by":"crossref","first-page":"e041122","DOI":"10.1136\/bmjopen-2020-041122","article-title":"Hypertension, cardiovascular disease and cause of death in Danish living kidney donors: matched cohort study.","volume":"10","author":"Chaudry","year":"2020","journal-title":"BMJ Open"},{"key":"R21-20260616","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1111\/ajt.16384","article-title":"Is the risk of cardiovascular disease increased in living kidney donors? A Danish population-based cohort study.","volume":"21","author":"Munch","year":"2021","journal-title":"Am J Transplant"},{"key":"R22-20260616","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12882-019-1214-4","article-title":"Long term metabolic and renal outcomes of kidney donors compared to controls with excellent kidney function.","volume":"20","author":"Grupper","year":"2019","journal-title":"BMC Nephrol"},{"key":"R23-20260616","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1097\/TP.0000000000003082","article-title":"Comparison of medium-term outcomes of living kidney donors with longitudinal healthy control in the United Kingdom.","volume":"104","author":"Krishnan","year":"2020","journal-title":"Transplantation"},{"key":"R24-20260616","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s10654-020-00647-y","article-title":"Long-term prognosis after kidney donation: a propensity score matched comparison of living donors and non-donors from two population cohorts.","volume":"35","author":"Janki","year":"2020","journal-title":"Eur J Epidemiol"},{"key":"R25-20260616","doi-asserted-by":"crossref","first-page":"e14494","DOI":"10.1097\/MD.0000000000014494","article-title":"Risk of subsequent health disorders among living kidney donors.","volume":"98","author":"Lin","year":"2019","journal-title":"Medicine (Baltim)"},{"key":"R26-20260616","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1161\/HYPERTENSIONAHA.115.06608","article-title":"Cardiovascular effects of unilateral nephrectomy in living kidney donors.","volume":"67","author":"Moody","year":"2016","journal-title":"Hypertension"},{"key":"R27-20260616","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.2215\/CJN.15651219","article-title":"Changes in blood pressure and arterial hemodynamics following living kidney donation.","volume":"15","author":"Price","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"key":"R28-20260616","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.kint.2020.01.017","article-title":"A prospective controlled study of metabolic and physiologic effects of kidney donation suggests that donors retain stable kidney function over the first nine years.","volume":"98","author":"Kasiske","year":"2020","journal-title":"Kidney Int"},{"key":"R29-20260616","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1001\/jama.2024.8523","article-title":"Hypertension and kidney function after living kidney donation.","volume":"332","author":"Garg","year":"2024","journal-title":"JAMA"},{"key":"R30-20260616","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1016\/j.jacc.2010.09.001","article-title":"2010 ACCF\/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines.","volume":"56","author":"Greenland","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"R31-20260616","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.2215\/CJN.14031118","article-title":"Risk of ESKD in older live kidney donors with hypertension.","volume":"14","author":"Al Ammary","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"key":"R32-20260616","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1111\/tri.13443","article-title":"Long-term risk for kidney donors with hypertension at donation\u2014a retrospective cohort study.","volume":"32","author":"Haugen","year":"2019","journal-title":"Transpl Int"},{"key":"R33-20260616","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1093\/ajh\/hpaf114","article-title":"Cardiovascular and kidney outcomes of living kidney donors with preexisting hypertension: a systematic review and meta-analysis.","volume":"39","author":"Eldaba","year":"2025","journal-title":"Am J Hypertens"},{"key":"R34-20260616","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.ekir.2021.02.034","article-title":"Outcomes of hypertensive kidney donors using current and past hypertension definitions.","volume":"6","author":"Ibrahim","year":"2021","journal-title":"Kidney Int Rep"},{"issue":"8S Suppl 1","key":"R37-20260616","first-page":"S1","article-title":"KDIGO clinical practice guideline on the evaluation and care of living kidney donors.","volume":"101","author":"Lentine","year":"2017","journal-title":"Transplantation"},{"issue":"10 Suppl 1","key":"R38-20260616","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/TP.0000000000000918","article-title":"Kidney paired donation protocol for participating donors 2014.","volume":"99","author":"Richardson","year":"2015","journal-title":"Transplantation"},{"key":"R39-20260616","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1093\/ndt\/gfu216","article-title":"European renal best practice guideline on kidney donor and recipient evaluation and perioperative care.","volume":"30","author":"Abramowicz","year":"2015","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl 1","key":"R40-20260616","first-page":"S114","article-title":"The CARI guidelines. Donors at risk: hypertension.","volume":"15","author":"Ierino","year":"2010","journal-title":"Nephrology (Carlton)"},{"issue":"6 Suppl","key":"R41-20260616","first-page":"S53","article-title":"A report of the Amsterdam forum on the care of the live kidney donor: data and medical guidelines.","volume":"79","author":"Delmonico","year":"2005","journal-title":"Transplantation"},{"key":"R42-20260616","doi-asserted-by":"crossref","first-page":"738","DOI":"10.2215\/CJN.02780218","article-title":"Diagnostic performance of blood pressure measurement modalities in living kidney donor candidates.","volume":"14","author":"Armanyous","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"key":"R43-20260616","first-page":"e212","article-title":"AHA\/ACC\/AANP\/AAPA\/ABC\/ACCP\/ACPM\/AGS\/AMA\/ASPC\/NMA\/PCNA\/SGIM Guideline for the prevention, detection, evaluation and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines.","volume":"2025","author":"Jones","year":"2025","journal-title":"Hypertension"},{"key":"R44-20260616","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1600-6143.2012.04303.x","article-title":"Medical outcomes in African American live kidney donors: a matched cohort study.","volume":"13","author":"Doshi","year":"2013","journal-title":"Am J Transplant"},{"key":"R45-20260616","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.jacc.2017.01.040","article-title":"Apolipoprotein L1 variants and blood pressure traits in African Americans.","volume":"69","author":"Nadkarni","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"R46-20260616","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1186\/s12882-025-04513-5","article-title":"Hypertension after living kidney donation: incidence, predictors, and consequences.","volume":"26","author":"Fernandes","year":"2025","journal-title":"BMC Nephrol"},{"key":"R47-20260616","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1016\/j.ajt.2024.04.023","article-title":"Consequences of low estimated glomerular filtration rate either before or early after kidney donation.","volume":"24","author":"Evans","year":"2024","journal-title":"Am J Transplant"},{"key":"R48-20260616","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1097\/TP.0000000000004505","article-title":"Development and validation of a hypertension risk calculator for living kidney donors.","volume":"107","author":"Helgeson","year":"2023","journal-title":"Transplantation"},{"key":"R49-20260616","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1111\/ajt.14713","article-title":"Hypertension after kidney donation: incidence, predictors, and correlates.","volume":"18","author":"Sanchez","year":"2018","journal-title":"Am J Transplant"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/TP.0000000000005735","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:18:35Z","timestamp":1786040315000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/TP.0000000000005735"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":45,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000005735","relation":{},"ISSN":["0041-1337","1534-6080"],"issn-type":[{"value":"0041-1337","type":"print"},{"value":"1534-6080","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,27]]}}}